carbonthatcarbonthat
← Every company

Who Owns Oramed Pharmaceuticals Inc

Every manager with more than $100m in listed equities files a 13F each quarter naming what they hold. These are the ones reporting a position in Oramed Pharmaceuticals Inc.

Who crossed 5% of ORMP →
Managers holding
2
as of 2026-09-30
Reported value
$3.1K
summed across filings
Shares held
670
Added vs trimmed
0 / 0
since each filer's last quarter

Positions as of 2026-09-30

Largest first. The move is against the previous quarter that manager filed, not the previous calendar quarter.

ManagerValue
Farther Finance Advisors, LLCStock486 sh—$2.3K
GAMMA Investing LLCCommon Stock184 sh—$859

Source: quarterly 13F filings, via EDGAR. A 13F reports positions by CUSIP alone; each CUSIP here has been confirmed against OpenFIGI rather than matched by name, because a name match would attribute one company's shareholders to another. Positions are as of quarter end and can be months old by the time they are filed, and 13F covers long equity positions only — not shorts, and not most debt. The summed value is what these filers reported, not the company's institutional ownership.

More on ORMP

Company overviewEverything on ORMP in one place, with the price.SEC filingsWhat ORMP's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat ORMP's own officers and directors buy and sell.Executive payWhat ORMP awarded its chief executive, and what it became.Funds holding itWhich funds and ETFs hold ORMP, and how big a bet.PatentsWhat ORMP is filing at the patent office.

Follow Oramed Pharmaceuticals Inc (ORMP) by email

New trades in Oramed Pharmaceuticals Inc (ORMP) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets

Whale MovesAnyone crossing five per cent, and whether they want a say.SectorsEvery company by sector and industry, with valuations.Stock ScreensPiotroski, Graham, dividend records and most shorted.Fund Manager CommentaryWhat well-known funds' managers say drove their year.